Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on January 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an ...
Associated Capital Group, Inc. (“AC” or the “Company”) (NYSE: AC), announced today a preliminary range for its fourth quarter book value of $42.04 to $42.24 per share. These estimates reflect the $2 ...
The Company intends to hold its annual meeting no later than December 31, 2025 in order to regain compliance under the NYSE American Company Guide. Matinas BioPharma is a biopharmaceutical company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback